Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Patterson-UTI Energy Adds 9% On Decision To Combine With NexTier Oilfield
  2. Bloomberg Strategist on $ETH vs $BTC: “Ethereum’s Upper Hand Could Be Enduring”
  3. Markets Cheer U.S. GDP Data While Waiting For Jackson Hole Cues
  4. MicroStrategy's Bitcoin Stash Now In The Green as Crypto Assets Soar
  5. Bellerophon Therapeutics Surges 30% On Share Subscription Agreement With An Institutional Investor